000 03245cam a2200349 a 4500
003 EG-GiCUC
005 20250223032514.0
008 200115s2020 ua dho f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.08.09.Ph.D.2020.Ze.A
100 0 _aZeinab Mohamed Abdelaziz Ismail Mohamed Awwad
245 1 0 _aAssessment of pregabalin-induced cardiovascular effects in experimental animals :
_bStudying the modulating effect of angiotensin 1-7 /
_cZeinab Mohamed Abdelaziz Ismail Mohamed Awwad ; Supervised Aiman S. Elkhatib , Mahmoud M. Khattab , Ahmed I. Elmallah
246 1 5 _aتقييم الآثار القلبية و الوعائية المحدثة بالبريجابالين فى حيوانات التجارب :
_bدراسة التأثير المعدل للأنجيوتنسين 1-7
260 _aCairo :
_bZeinab Mohamed Abdelaziz Ismail Mohamed Awwad ,
_c2020
300 _a138 P. :
_bcharts , facsimiles , photographs ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology
520 _aPregabalin (PRG) is highly effective in the treatment of epilepsy, neuropathic pain and anxiety disorders. Despite its potential benefits, PRG administration has been reported to induce or exacerbate heart failure (HF). Overactivation of renin angiotensin system (RAS) plays a pivotal role in HF pathophysiological mechanism. To further emphasize the role of RAS in PRG-induced HF pathological mechanism, the protective potential of diminazene aceturate (DIZE), an angiotensin converting enzyme 2 (ACE2) activator, was investigated. PRG administration induced morphometric, echocardiographic and histopathological deleterious alterations and significantly elevated cardiac angiotensin II (Ang II), angiotensin converting enzyme (ACE) and angiotensin II type 1 receptor (AT1R) levels, while reduced angiotensin 1-7 (Ang 1-7), ACE2 and Mas receptor (MasR) cardiac levels. DIZE co-administration showed prominent protection against PRG-induced cardiac alterations in rats. Downregulation of ACE/Ang II/AT1R and upregulation of ACE2/Ang 1-7/MasR axes were noted in DIZE co-treated rats. These findings showed, for the first time, the detailed cardiac deleterious effects of PRG in rats. Moreover, the current study examined the possible cardioprotective effect of telmisartan (Tel), an AT1R blocker, compared with that of captopril (Cap), an ACE inhibitor, in ameliorating PRG-induced HF in rats by assessing morphometric, echocardiographic and histopathological aspects. Furthermore, the role of RAS modulation by the two drugs in guarding against PRG-induced changes in cardiac Ang 1-7 and Ang II levels, in addition to myocardial expression of ACE2, ACE, MasR and AT1R was investigated
530 _aIssued also as CD
653 4 _aDiminazene aceturate
653 4 _aHeart failure
653 4 _aPregabalin
700 0 _aAhmed I. Elmallah ,
_eSupervisor
700 0 _aAiman S. Elkhatib ,
_eSupervisor
700 0 _aMahmoud M. Khattab ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aAsmaa
_eCataloger
905 _aNazla
_eRevisor
942 _2ddc
_cTH
999 _c76353
_d76353